Related Experiment Video
Updated: May 24, 2026
11:17
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Heparin-induced thrombocytopenia: an update
Margaret Prechel1, Jeanine M Walenga
1Department of Pathology, Stritch School of Medicine, Loyola University Chicago, Maywood, IL, USA.
Seminars in Thrombosis and Hemostasis
|March 9, 2012
Summary
Heparin-induced thrombocytopenia (HIT) requires prompt diagnosis and management. Early detection and treatment with non-heparin anticoagulants significantly improve patient outcomes for this serious heparin complication.
Area of Science:
- Immunology
- Hematology
- Pharmacology
Background:
- Heparin-induced thrombocytopenia (HIT) is a critical immune reaction to heparin.
- HIT can lead to severe complications including thrombosis, amputation, and mortality.
- Accurate diagnosis and management are essential for affected patients.
Purpose of the Study:
- To review the clinical management of Heparin-induced thrombocytopenia (HIT).
- To highlight the importance of early diagnosis and appropriate laboratory testing.
- To discuss current and emerging treatment strategies for HIT.
Main Methods:
- Comprehensive review of clinical and laboratory findings for HIT diagnosis.
- Analysis of monitoring protocols during and after heparin exposure.
- Evaluation of non-heparin anticoagulant therapies and long-term management.
Main Results:
- Early diagnosis through integrated clinical and lab data improves outcomes.
- Laboratory tests for HIT vary in sensitivity and specificity, requiring careful interpretation.
- Non-heparin anticoagulants (e.g., direct thrombin inhibitors, danaparoid) are primary treatments, followed by vitamin K antagonists.
Conclusions:
- Timely diagnosis and management of HIT are crucial to prevent severe outcomes.
- Understanding limitations and guidelines for anticoagulants is vital for patient safety.
- Ongoing research addresses unresolved issues and unmet needs in HIT management.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...